Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | CRNX |
---|---|---|
09:32 ET | 3610 | 51.01 |
09:34 ET | 400 | 50.45 |
09:36 ET | 100 | 50.51 |
09:38 ET | 874 | 50.44 |
09:39 ET | 200 | 50.65 |
09:41 ET | 200 | 50.88 |
09:43 ET | 905 | 50.895 |
09:45 ET | 300 | 51.145 |
09:48 ET | 7166 | 51.095 |
09:50 ET | 414 | 50.98 |
09:52 ET | 354 | 50.8 |
09:54 ET | 100 | 50.785 |
09:56 ET | 100 | 50.75 |
09:59 ET | 400 | 50.47 |
10:01 ET | 1452 | 50.49 |
10:06 ET | 500 | 50.4531 |
10:08 ET | 387 | 50.79 |
10:10 ET | 100 | 50.45 |
10:12 ET | 100 | 50.45 |
10:14 ET | 1000 | 50.46 |
10:15 ET | 1085 | 50.36 |
10:17 ET | 709 | 50.52 |
10:19 ET | 300 | 50.475 |
10:21 ET | 1112 | 50.47 |
10:24 ET | 400 | 50.41 |
10:26 ET | 400 | 50.53 |
10:28 ET | 100 | 50.5808 |
10:30 ET | 100 | 50.48 |
10:32 ET | 1700 | 50.52 |
10:33 ET | 400 | 50.53 |
10:35 ET | 410 | 50.49 |
10:37 ET | 200 | 50.55 |
10:39 ET | 1600 | 50.685 |
10:42 ET | 300 | 50.675 |
10:44 ET | 814 | 50.76 |
10:46 ET | 878 | 50.92 |
10:48 ET | 500 | 50.9 |
10:51 ET | 300 | 51.03 |
10:53 ET | 800 | 50.96 |
10:55 ET | 110 | 50.89 |
10:57 ET | 914 | 50.78 |
11:00 ET | 806 | 50.83 |
11:02 ET | 1409 | 50.98 |
11:04 ET | 400 | 50.885 |
11:06 ET | 599 | 50.875 |
11:08 ET | 300 | 50.87 |
11:11 ET | 700 | 50.9 |
11:13 ET | 1256 | 50.91 |
11:15 ET | 564 | 50.9 |
11:18 ET | 400 | 50.92 |
11:20 ET | 100 | 50.9 |
11:22 ET | 708 | 50.7 |
11:24 ET | 900 | 50.77 |
11:26 ET | 378 | 50.77 |
11:27 ET | 382 | 50.725 |
11:31 ET | 946 | 50.76 |
11:33 ET | 607 | 50.805 |
11:36 ET | 500 | 50.955 |
11:38 ET | 369 | 50.79 |
11:40 ET | 409 | 50.79 |
11:42 ET | 2434 | 50.885 |
11:44 ET | 200 | 50.99 |
11:45 ET | 200 | 50.9 |
11:47 ET | 289 | 50.93 |
11:51 ET | 400 | 50.88 |
11:56 ET | 100 | 50.905 |
11:58 ET | 800 | 50.99 |
12:00 ET | 400 | 50.95 |
12:02 ET | 100 | 50.9 |
12:03 ET | 200 | 50.9 |
12:05 ET | 900 | 50.84 |
12:07 ET | 2684 | 50.86 |
12:12 ET | 7732 | 50.74 |
12:14 ET | 100 | 50.735 |
12:16 ET | 600 | 50.83 |
12:18 ET | 100 | 50.83 |
12:20 ET | 222 | 50.765 |
12:21 ET | 103 | 50.7144 |
12:23 ET | 200 | 50.71 |
12:27 ET | 592 | 50.68 |
12:30 ET | 336 | 50.67 |
12:32 ET | 500 | 50.61 |
12:34 ET | 2967 | 50.7 |
12:36 ET | 200 | 50.695 |
12:39 ET | 1123 | 50.75 |
12:41 ET | 100 | 50.72 |
12:45 ET | 300 | 50.6545 |
12:48 ET | 200 | 50.63 |
12:52 ET | 200 | 50.7 |
12:56 ET | 500 | 50.72 |
12:57 ET | 400 | 50.69 |
01:01 ET | 500 | 50.785 |
01:06 ET | 200 | 50.85 |
01:08 ET | 100 | 50.78 |
01:10 ET | 981 | 50.81 |
01:14 ET | 600 | 50.78 |
01:17 ET | 1642 | 50.87 |
01:19 ET | 200 | 50.855 |
01:21 ET | 300 | 50.84 |
01:24 ET | 108 | 50.87 |
01:26 ET | 1224 | 51.08 |
01:28 ET | 332 | 51.09 |
01:30 ET | 400 | 51.1 |
01:32 ET | 1461 | 51.07 |
01:33 ET | 269 | 51.205 |
01:37 ET | 200 | 51.17 |
01:39 ET | 200 | 51.11 |
01:42 ET | 300 | 51.15 |
01:44 ET | 221 | 51.23 |
01:46 ET | 100 | 51.18 |
01:51 ET | 120 | 51.295 |
01:53 ET | 200 | 51.35 |
01:55 ET | 645 | 51.31 |
01:57 ET | 204 | 51.24 |
02:00 ET | 557 | 51.225 |
02:02 ET | 800 | 51.15 |
02:04 ET | 200 | 51.14 |
02:08 ET | 300 | 51.14 |
02:09 ET | 300 | 51.14 |
02:11 ET | 100 | 51.15 |
02:13 ET | 3757 | 51.14 |
02:15 ET | 673 | 51.14 |
02:18 ET | 515 | 51.18 |
02:20 ET | 325 | 51.1 |
02:24 ET | 200 | 51.03 |
02:26 ET | 506 | 50.99 |
02:27 ET | 908 | 50.83 |
02:29 ET | 913 | 50.85 |
02:31 ET | 100 | 50.75 |
02:33 ET | 17062 | 51.02 |
02:36 ET | 408 | 50.95 |
02:38 ET | 222 | 50.94 |
02:40 ET | 100 | 50.945 |
02:42 ET | 200 | 50.995 |
02:44 ET | 550 | 51.025 |
02:45 ET | 200 | 50.96 |
02:47 ET | 931 | 51.03 |
02:51 ET | 715 | 51.045 |
02:54 ET | 200 | 51.01 |
02:56 ET | 100 | 51.035 |
02:58 ET | 800 | 51.01 |
03:00 ET | 1173 | 51.01 |
03:02 ET | 600 | 51.005 |
03:03 ET | 100 | 50.99 |
03:05 ET | 215 | 50.92 |
03:07 ET | 100 | 50.97 |
03:09 ET | 400 | 50.94 |
03:12 ET | 478 | 50.92 |
03:14 ET | 1750 | 50.94 |
03:16 ET | 435 | 50.965 |
03:18 ET | 300 | 50.9 |
03:20 ET | 400 | 50.895 |
03:21 ET | 400 | 50.84 |
03:23 ET | 200 | 50.96 |
03:25 ET | 600 | 50.935 |
03:27 ET | 100 | 50.93 |
03:30 ET | 700 | 51.03 |
03:32 ET | 1207 | 50.89 |
03:34 ET | 413 | 50.87 |
03:36 ET | 600 | 50.775 |
03:38 ET | 108 | 50.77 |
03:39 ET | 2183 | 50.785 |
03:41 ET | 1902 | 50.735 |
03:43 ET | 800 | 50.77 |
03:45 ET | 305 | 50.7225 |
03:48 ET | 300 | 50.78 |
03:50 ET | 715 | 50.74 |
03:52 ET | 1470 | 50.82 |
03:54 ET | 300 | 50.76 |
03:56 ET | 3782 | 50.7 |
03:57 ET | 3280 | 50.72 |
03:59 ET | 92849 | 50.75 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
Crinetics Pharmaceuticals Inc | 4.0B | -13.5x | --- |
Immunovant Inc | 4.1B | -14.6x | --- |
BridgeBio Pharma Inc | 4.6B | -9.5x | --- |
Dyne Therapeutics Inc | 3.5B | -9.4x | --- |
Madrigal Pharmaceuticals Inc | 4.6B | -8.3x | --- |
Apogee Therapeutics Inc | 3.4B | -25.8x | --- |
Crinetics Pharmaceuticals, Inc. is a clinical-stage pharmaceutical company focused on the discovery, development and commercialization of therapeutics for rare endocrine diseases and endocrine-related tumors. Its Paltusotine, an investigational, oral somatostatin receptor type 2 (SST2) agonist, is in Phase 3 clinical development for acromegaly and Phase 2 clinical development for carcinoid syndrome associated with neuroendocrine tumors. It has demonstrated pharmacologic proof-of-concept in a Phase 1 clinical study for CRN04894, an investigational, oral ACTH antagonist, that is in Phase 2 clinical studies for the treatment of congenital adrenal hyperplasia and Cushing's disease. Its drug candidates are orally delivered, small molecule new chemical entities resulting from in-house drug discovery efforts, including other programs addressing a variety of endocrine conditions such as hyperparathyroidism, polycystic kidney disease, Graves' disease, thyroid eye disease, diabetes and obesity.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $4.0B |
---|---|
Revenue (TTM) | $1.4M |
Shares Outstanding | 80.0M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 0.64 |
EPS | $-3.77 |
Book Value | $7.91 |
P/E Ratio | -13.5x |
Price/Sales (TTM) | 2,922.9 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -20,068.38% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.